...
首页> 外文期刊>Proteome science >Clinical proteomics and OMICS clues useful in translational medicine research
【24h】

Clinical proteomics and OMICS clues useful in translational medicine research

机译:临床蛋白质组学和OMICS线索可用于转化医学研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Since the advent of the new proteomics era more than a decade ago, large-scale studies of protein profiling have been used to identify distinctive molecular signatures in a wide array of biological systems, spanning areas of basic biological research, clinical diagnostics, and biomarker discovery directed toward therapeutic applications. Recent advances in protein separation and identification techniques have significantly improved proteomic approaches, leading to enhancement of the depth and breadth of proteome coverage. Proteomic signatures, specific for multiple diseases, including cancer and pre-invasive lesions, are emerging. This article combines, in a simple manner, relevant proteomic and OMICS clues used in the discovery and development of diagnostic and prognostic biomarkers that are applicable to all clinical fields, thus helping to improve applications of clinical proteomic strategies for translational medicine research.
机译:自十多年前的新蛋白质组学时代问世以来,蛋白质谱的大规模研究已用于识别广泛的生物系统中的独特分子标记,涵盖了基础生物学研究,临床诊断和生物标志物发现领域针对治疗应用。蛋白质分离和鉴定技术的最新进展已大大改善了蛋白质组学方法,从而提高了蛋白质组覆盖的深度和广度。专门针对多种疾病(包括癌症和浸润前病变)的蛋白质组学特征正在出现。本文以简单的方式结合了蛋白质组学和OMICS线索,这些线索用于发现和开发适用于所有临床领域的诊断和预后生物标志物,从而有助于改善临床蛋白质组学策略在转化医学研究中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号